Dr. Reddy's relaunches generic Accutane
Dr. Reddy’s is relaunching Zenatane (isotretinoin capsules), its generic of Roche’s Accutane. The product will be available in dosage strengths of 10 mg, 20 mg, 30 mg and 40 mg.
The product is indicated for treating severe acne.
“We’re pleased to bring this important product back to market for the customers and patients who will benefit from access to this medicine and who have had witnessed limited supply and options in the market place,” Dr. Reddy’s CEO North America generics Marc Kikuchi said. “Furthermore, this is important for our company as we have commercialized the first Softgel dosage product from Dr. Reddy’s own manufacturing plant to ensure consistent and robust supply for this product in the U.S. market.”
The product had a branded and generic market value of roughly $525 million for the most recent 12 months ended in March 2019 according to IQVIA data.
The product is indicated for treating severe acne.
“We’re pleased to bring this important product back to market for the customers and patients who will benefit from access to this medicine and who have had witnessed limited supply and options in the market place,” Dr. Reddy’s CEO North America generics Marc Kikuchi said. “Furthermore, this is important for our company as we have commercialized the first Softgel dosage product from Dr. Reddy’s own manufacturing plant to ensure consistent and robust supply for this product in the U.S. market.”
The product had a branded and generic market value of roughly $525 million for the most recent 12 months ended in March 2019 according to IQVIA data.